Working with a contract drug manufacturing and testing firm in the United Kingdom, 25 to 30 healthy volunteers are now ...
Deutsche Bank upgraded Gilead Sciences (NASDAQ:GILD) on Tuesday, citing the antiviral developer’s HIV treatment franchise, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback